English

VioQuest Pharmaceuticals, Inc.

EDGAR

Quarterly report (10-Q) · filed 2008-08-19

60 filing records in this dataset, filed from 1995-09-25 to 2008-08-19. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2007-06-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-1 million USD

2007-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -2693485 USD Source
Operating Cash Flow: -1689206 USD Source

Cash and cash equivalents: 814 thousand USD 2008-06-30 Source
Exact value

814477 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

0 USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Capital expenditure: 0 USD · 1998-01-01 – 1998-12-31 Source
Capital expenditure: 0 USD · 1998-01-01 – 1998-09-30 Source
Capital expenditure: 0 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 0 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 0 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 0 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 0 USD · 1999-01-01 – 1999-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-08-19.

Financial data available through: 2003-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2003-12-31
Operating income: 9 of 11 periods available· newest 2003-12-31
Net income: 9 of 11 periods available· newest 2003-12-31
Operating cash flow: 8 of 11 periods available· newest 2002-12-31
Capital expenditure: 6 of 11 periods available· newest 2001-12-31
Total assets: 9 of 11 periods available· newest 2003-12-31
Total liabilities: 3 of 11 periods available· newest 2003-12-31
Current assets: 9 of 11 periods available· newest 2003-12-31
Current liabilities: 9 of 11 periods available· newest 2003-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2003-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+249.2%

Prior period

USD 191,613

2002-01-01 – 2002-12-31
Current period

USD 669,036

2003-01-01 – 2003-12-31

Exact inputs and evidence

669036 − 191613 = 477423 USD

191613 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
669036 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · VioQuest Pharmaceuticals, Inc. · 2003-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Year-over-year change in Revenue: 477423 USD Concept: fundies:Revenue Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 669036 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0001144204-04-003637.txt#3766 Input fundies:Revenue: 191613 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0001144204-04-003637.txt#3766
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 1.48 million

Prior period

−USD 537,978

2002-01-01 – 2002-12-31
Current period

−USD 2.02 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

-2018400 − -537978 = -1480422 USD

-537978 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
-2018400 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · VioQuest Pharmaceuticals, Inc. · 2003-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Year-over-year change in Net income: -1480422 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2018400 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0001144204-04-003637.txt#3987 Input fundies:NetIncome: -537978 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0001144204-04-003637.txt#3987
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2003 2003-01-01 – 2003-12-31

Revenue USD 669,036 100% of revenue
Cost of revenue USD 196,045 29% of revenue
Operating expenses USD 2.5 million 374% of revenue
Operating income −USD 2.03 million −303% of revenue
Tax, interest and other Derived −USD 11,164 −1.7% of revenue
Net income −USD 2.02 million −302% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 98%
1996 Operating loss: operating costs were 102% of revenue.
1997 Operating loss: operating costs were 114% of revenue.
1998 100%
1999 Operating loss: operating costs were 126% of revenue.
2000 Operating loss: operating costs were 144% of revenue.
2001 Operating loss: operating costs were 144% of revenue.
2002 Operating loss: operating costs were 381% of revenue.
2003 Operating loss: operating costs were 403% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	691471	680589 Derived	10882	10007 Derived	875	-17017 Derived	Source 1995-01-01 – 1995-12-31: 691471 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: 10882 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: 875 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -7777 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 9240 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	634509	645434 Derived	-10925	7180 Derived	-18105	1852 Derived	Source 1996-01-01 – 1996-12-31: 634509 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -10925 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -18105 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: 1852 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 0 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	486761	553903 Derived	-67142	2785 Derived	-69927	-17052 Derived	Source 1997-01-01 – 1997-12-31: 486761 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -67142 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -69927 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -12348 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 4704 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	573054	570682 Derived	2372	605 Derived	1767	-32531 Derived	Source 1998-01-01 – 1998-12-31: 573054 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: 2372 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: 1767 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -32531 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 0 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	633584	800830 Derived	-167246	-210997 Derived	43751	Unavailable	Source 1999-01-01 – 1999-12-31: 633584 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -167246 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: 43751 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 59026 USD Inspect Operating Cash Flow Open source
2000 2000-01-01 – 2000-12-31	440234000	633249000 Derived	-193015000	5074000 Derived	-198089000	57996 Derived	Source 2000-01-01 – 2000-12-31: 440234000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -193015000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -198089000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: 59026 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 1030 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	440234	633249 Derived	-193015	5074 Derived	-198089	-15641 Derived	Source 2001-01-01 – 2001-12-31: 440234 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -193015 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -198089 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -15641 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 0 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	191613	729591 Derived	-537978	0 Derived	-537978	Unavailable	Source 2002-01-01 – 2002-12-31: 191613 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -537978 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -537978 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -115958 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	669036	2698600 Derived	-2029564	-11164 Derived	-2018400	Unavailable	Source 2003-01-01 – 2003-12-31: 669036 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -2029564 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -2018400 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 669K 2003

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Revenue	691471	Revenue: 691471 Open source
19961996-12-31	Revenue	634509	Revenue: 634509 Open source
19971997-12-31	Revenue	486761	Revenue: 486761 Open source
19981998-12-31	Revenue	573054	Revenue: 573054 Open source
19991999-12-31	Revenue	633584	Revenue: 633584 Open source
20002000-12-31	Revenue	440234000	Revenue: 440234000 Open source
20012001-12-31	Revenue	440234	Revenue: 440234 Open source
20022002-12-31	Revenue	191613	Revenue: 191613 Open source
20032003-12-31	Revenue	669036	Revenue: 669036 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

249.2% 2003

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	No prior comparable period	Revenue: 691471 Open source
19961996-12-31	Year over year	-8.2%	Revenue: 634509 Open source Revenue: 691471 Open source
19971997-12-31	Year over year	-23.3%	Revenue: 486761 Open source Revenue: 634509 Open source
19981998-12-31	Year over year	17.7%	Revenue: 573054 Open source Revenue: 486761 Open source
19991999-12-31	Year over year	10.6%	Revenue: 633584 Open source Revenue: 573054 Open source
20002000-12-31	Year over year	69,383.1%	Revenue: 440234000 Open source Revenue: 633584 Open source
20012001-12-31	Year over year	-99.9%	Revenue: 440234 Open source Revenue: 440234000 Open source
20022002-12-31	Year over year	-56.5%	Revenue: 191613 Open source Revenue: 440234 Open source
20032003-12-31	Year over year	249.2%	Revenue: 669036 Open source Revenue: 191613 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -303.4% 2003

Net margin -301.7% 2003

Free cash flow margin -3.6% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Operating margin	1.6%	Operating Income: 10882 Open source Revenue: 691471 Open source
19961996-12-31	Operating margin	-1.7%	Operating Income: -10925 Open source Revenue: 634509 Open source
19971997-12-31	Operating margin	-13.8%	Operating Income: -67142 Open source Revenue: 486761 Open source
19981998-12-31	Operating margin	0.4%	Operating Income: 2372 Open source Revenue: 573054 Open source
19991999-12-31	Operating margin	-26.4%	Operating Income: -167246 Open source Revenue: 633584 Open source
20002000-12-31	Operating margin	-43.8%	Operating Income: -193015000 Open source Revenue: 440234000 Open source
20012001-12-31	Operating margin	-43.8%	Operating Income: -193015 Open source Revenue: 440234 Open source
20022002-12-31	Operating margin	-280.8%	Operating Income: -537978 Open source Revenue: 191613 Open source
20032003-12-31	Operating margin	-303.4%	Operating Income: -2029564 Open source Revenue: 669036 Open source
19951995-12-31	Net margin	0.1%	Net Income: 875 Open source Revenue: 691471 Open source
19961996-12-31	Net margin	-2.9%	Net Income: -18105 Open source Revenue: 634509 Open source
19971997-12-31	Net margin	-14.4%	Net Income: -69927 Open source Revenue: 486761 Open source
19981998-12-31	Net margin	0.3%	Net Income: 1767 Open source Revenue: 573054 Open source
19991999-12-31	Net margin	6.9%	Net Income: 43751 Open source Revenue: 633584 Open source
20002000-12-31	Net margin	-45%	Net Income: -198089000 Open source Revenue: 440234000 Open source
20012001-12-31	Net margin	-45%	Net Income: -198089 Open source Revenue: 440234 Open source
20022002-12-31	Net margin	-280.8%	Net Income: -537978 Open source Revenue: 191613 Open source
20032003-12-31	Net margin	-301.7%	Net Income: -2018400 Open source Revenue: 669036 Open source
19951995-12-31	Free cash flow margin	-2.5%	Revenue: 691471 Open source Operating Cash Flow: -7777 Open source Capital Expenditure: 9240 Open source
19961996-12-31	Free cash flow margin	0.3%	Revenue: 634509 Open source Operating Cash Flow: 1852 Open source Capital Expenditure: 0 Open source
19971997-12-31	Free cash flow margin	-3.5%	Revenue: 486761 Open source Operating Cash Flow: -12348 Open source Capital Expenditure: 4704 Open source
19981998-12-31	Free cash flow margin	-5.7%	Revenue: 573054 Open source Operating Cash Flow: -32531 Open source Capital Expenditure: 0 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 633584 Open source Operating Cash Flow: 59026 Open source
20002000-12-31	Free cash flow margin	0%	Revenue: 440234000 Open source Operating Cash Flow: 59026 Open source Capital Expenditure: 1030 Open source
20012001-12-31	Free cash flow margin	-3.6%	Revenue: 440234 Open source Operating Cash Flow: -15641 Open source Capital Expenditure: 0 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 191613 Open source Operating Cash Flow: -115958 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 669036 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -116K 2002

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	-7777	Operating Cash Flow: -7777 Open source
19961996-12-31	Operating cash flow	1852	Operating Cash Flow: 1852 Open source
19971997-12-31	Operating cash flow	-12348	Operating Cash Flow: -12348 Open source
19981998-12-31	Operating cash flow	-32531	Operating Cash Flow: -32531 Open source
19991999-12-31	Operating cash flow	59026	Operating Cash Flow: 59026 Open source
20002000-12-31	Operating cash flow	59026	Operating Cash Flow: 59026 Open source
20012001-12-31	Operating cash flow	-15641	Operating Cash Flow: -15641 Open source
20022002-12-31	Operating cash flow	-115958	Operating Cash Flow: -115958 Open source
20032003-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -15.6K 2001

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	-17017	Operating Cash Flow: -7777 Open source Capital Expenditure: 9240 Open source
19961996-12-31	Free cash flow	1852	Operating Cash Flow: 1852 Open source Capital Expenditure: 0 Open source
19971997-12-31	Free cash flow	-17052	Operating Cash Flow: -12348 Open source Capital Expenditure: 4704 Open source
19981998-12-31	Free cash flow	-32531	Operating Cash Flow: -32531 Open source Capital Expenditure: 0 Open source
19991999-12-31	Free cash flow	Unavailable	Operating Cash Flow: 59026 Open source
20002000-12-31	Free cash flow	57996	Operating Cash Flow: 59026 Open source Capital Expenditure: 1030 Open source
20012001-12-31	Free cash flow	-15641	Operating Cash Flow: -15641 Open source Capital Expenditure: 0 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: -115958 Open source
20032003-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

48% 2003

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Liabilities / assets	Not reported	Total Assets: 385253 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 403029 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 303157 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 298423 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 346410 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 309545 Open source
20012001-12-31	Liabilities / assets	122.3%	Total Liabilities: 256000 Open source Total Assets: 209380 Open source
20022002-12-31	Liabilities / assets	187.3%	Total Liabilities: 860884 Open source Total Assets: 459729 Open source
20032003-12-31	Liabilities / assets	48%	Total Liabilities: 760523 Open source Total Assets: 1585857 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.16× 2003

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Current assets / current liabilities	2.32×	Current Assets: 321616 Open source Current Liabilities: 138440 Open source
19961996-12-31	Current assets / current liabilities	2.2×	Current Assets: 368206 Open source Current Liabilities: 167491 Open source
19971997-12-31	Current assets / current liabilities	1.95×	Current Assets: 274512 Open source Current Liabilities: 140675 Open source
19981998-12-31	Current assets / current liabilities	2.06×	Current Assets: 278510 Open source Current Liabilities: 135057 Open source
19991999-12-31	Current assets / current liabilities	2.23×	Current Assets: 329384 Open source Current Liabilities: 147810 Open source
20002000-12-31	Current assets / current liabilities	1.87×	Current Assets: 276161 Open source Current Liabilities: 147810 Open source
20012001-12-31	Current assets / current liabilities	0.76×	Current Assets: 189839 Open source Current Liabilities: 250731 Open source
20022002-12-31	Current assets / current liabilities	0.11×	Current Assets: 74398 Open source Current Liabilities: 687801 Open source
20032003-12-31	Current assets / current liabilities	1.16×	Current Assets: 837766 Open source Current Liabilities: 721407 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1995-01-01 – 1995-12-31	USD 875 Exact value Exact value: 875 USD 1995-01-01 – 1995-12-31: 875 USD Inspect Net Income Open source Share or cite Citation for Net Income · VioQuest Pharmaceuticals, Inc. · 1995-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Net Income: 875 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: 875 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-97-000001.txt#612 The citation records this snapshot. The page link may show a newer release later.	−USD 7,777 Exact value Exact value: -7777 USD 1995-01-01 – 1995-12-31: -7777 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VioQuest Pharmaceuticals, Inc. · 1995-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Operating Cash Flow: -7777 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7777 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-97-000001.txt#628 The citation records this snapshot. The page link may show a newer release later.	USD 9,240 Exact value Exact value: 9240 USD 1995-01-01 – 1995-12-31: 9240 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VioQuest Pharmaceuticals, Inc. · 1995-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Capital Expenditure: 9240 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9240 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-97-000001.txt#631 The citation records this snapshot. The page link may show a newer release later.	−USD 17,017 Calculation and evidence -7777 − 9240 USD Exact free cash flow: -17017 USD 1995-01-01 – 1995-12-31: -7777 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 9240 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VioQuest Pharmaceuticals, Inc. · 1995-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Free cash flow: -17017 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7777 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-97-000001.txt#628 Input fundies:CapitalExpenditure: 9240 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-97-000001.txt#631 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 18,105 Exact value Exact value: -18105 USD 1996-01-01 – 1996-12-31: -18105 USD Inspect Net Income Open source Share or cite Citation for Net Income · VioQuest Pharmaceuticals, Inc. · 1996-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Net Income: -18105 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18105 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-98-000002.txt#594 The citation records this snapshot. The page link may show a newer release later.	USD 1,852 Exact value Exact value: 1852 USD 1996-01-01 – 1996-12-31: 1852 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VioQuest Pharmaceuticals, Inc. · 1996-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Operating Cash Flow: 1852 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1852 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-98-000002.txt#609 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 1996-01-01 – 1996-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VioQuest Pharmaceuticals, Inc. · 1996-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-98-000002.txt#612 The citation records this snapshot. The page link may show a newer release later.	USD 1,852 Calculation and evidence 1852 − 0 USD Exact free cash flow: 1852 USD 1996-01-01 – 1996-12-31: 1852 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VioQuest Pharmaceuticals, Inc. · 1996-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Free cash flow: 1852 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1852 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-98-000002.txt#609 Input fundies:CapitalExpenditure: 0 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-98-000002.txt#612 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 69,927 Exact value Exact value: -69927 USD 1997-01-01 – 1997-12-31: -69927 USD Inspect Net Income Open source Share or cite Citation for Net Income · VioQuest Pharmaceuticals, Inc. · 1997-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Net Income: -69927 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -69927 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-99-000001.txt#616 The citation records this snapshot. The page link may show a newer release later.	−USD 12,348 Exact value Exact value: -12348 USD 1997-01-01 – 1997-12-31: -12348 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VioQuest Pharmaceuticals, Inc. · 1997-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Operating Cash Flow: -12348 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12348 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-99-000001.txt#630 The citation records this snapshot. The page link may show a newer release later.	USD 4,704 Exact value Exact value: 4704 USD 1997-01-01 – 1997-12-31: 4704 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VioQuest Pharmaceuticals, Inc. · 1997-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Capital Expenditure: 4704 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4704 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-99-000001.txt#633 The citation records this snapshot. The page link may show a newer release later.	−USD 17,052 Calculation and evidence -12348 − 4704 USD Exact free cash flow: -17052 USD 1997-01-01 – 1997-12-31: -12348 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 4704 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VioQuest Pharmaceuticals, Inc. · 1997-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Free cash flow: -17052 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12348 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-99-000001.txt#630 Input fundies:CapitalExpenditure: 4704 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-99-000001.txt#633 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	USD 1,767 Exact value Exact value: 1767 USD 1998-01-01 – 1998-12-31: 1767 USD Inspect Net Income Open source Share or cite Citation for Net Income · VioQuest Pharmaceuticals, Inc. · 1998-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Net Income: 1767 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1767 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-00-000002.txt#583 The citation records this snapshot. The page link may show a newer release later.	−USD 32,531 Exact value Exact value: -32531 USD 1998-01-01 – 1998-12-31: -32531 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VioQuest Pharmaceuticals, Inc. · 1998-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Operating Cash Flow: -32531 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32531 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-00-000002.txt#598 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 1998-01-01 – 1998-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VioQuest Pharmaceuticals, Inc. · 1998-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-99-000001.txt#633 The citation records this snapshot. The page link may show a newer release later.	−USD 32,531 Calculation and evidence -32531 − 0 USD Exact free cash flow: -32531 USD 1998-01-01 – 1998-12-31: -32531 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VioQuest Pharmaceuticals, Inc. · 1998-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Free cash flow: -32531 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32531 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-00-000002.txt#598 Input fundies:CapitalExpenditure: 0 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-99-000001.txt#633 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	USD 43,751 Exact value Exact value: 43751 USD 1999-01-01 – 1999-12-31: 43751 USD Inspect Net Income Open source Share or cite Citation for Net Income · VioQuest Pharmaceuticals, Inc. · 1999-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Net Income: 43751 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: 43751 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-01-500018.txt#606 The citation records this snapshot. The page link may show a newer release later.	USD 59,026 Exact value Exact value: 59026 USD 1999-01-01 – 1999-12-31: 59026 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VioQuest Pharmaceuticals, Inc. · 1999-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Operating Cash Flow: 59026 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 59026 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-00-000002.txt#598 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 198.09 million Exact value Exact value: -198089000 USD 2000-01-01 – 2000-12-31: -198089000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VioQuest Pharmaceuticals, Inc. · 2000-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Net Income: -198089000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -198089000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-02-000011.txt#607 The citation records this snapshot. The page link may show a newer release later.	USD 59,026 Exact value Exact value: 59026 USD 2000-01-01 – 2000-12-31: 59026 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VioQuest Pharmaceuticals, Inc. · 2000-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Operating Cash Flow: 59026 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 59026 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-01-500018.txt#674 The citation records this snapshot. The page link may show a newer release later.	USD 1,030 Exact value Exact value: 1030 USD 2000-01-01 – 2000-12-31: 1030 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VioQuest Pharmaceuticals, Inc. · 2000-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Capital Expenditure: 1030 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1030 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-01-500018.txt#678 The citation records this snapshot. The page link may show a newer release later.	USD 57,996 Calculation and evidence 59026 − 1030 USD Exact free cash flow: 57996 USD 2000-01-01 – 2000-12-31: 59026 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 1030 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VioQuest Pharmaceuticals, Inc. · 2000-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Free cash flow: 57996 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 59026 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-01-500018.txt#674 Input fundies:CapitalExpenditure: 1030 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-01-500018.txt#678 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 198,089 Exact value Exact value: -198089 USD 2001-01-01 – 2001-12-31: -198089 USD Inspect Net Income Open source Share or cite Citation for Net Income · VioQuest Pharmaceuticals, Inc. · 2001-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Net Income: -198089 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -198089 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000950134-03-001854.txt#3114 The citation records this snapshot. The page link may show a newer release later.	−USD 15,641 Exact value Exact value: -15641 USD 2001-01-01 – 2001-12-31: -15641 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VioQuest Pharmaceuticals, Inc. · 2001-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Operating Cash Flow: -15641 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15641 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000950134-03-001854.txt#3287 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2001-01-01 – 2001-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VioQuest Pharmaceuticals, Inc. · 2001-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-02-000011.txt#684 The citation records this snapshot. The page link may show a newer release later.	−USD 15,641 Calculation and evidence -15641 − 0 USD Exact free cash flow: -15641 USD 2001-01-01 – 2001-12-31: -15641 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VioQuest Pharmaceuticals, Inc. · 2001-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Free cash flow: -15641 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15641 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000950134-03-001854.txt#3287 Input fundies:CapitalExpenditure: 0 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000745788-02-000011.txt#684 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 537,978 Exact value Exact value: -537978 USD 2002-01-01 – 2002-12-31: -537978 USD Inspect Net Income Open source Share or cite Citation for Net Income · VioQuest Pharmaceuticals, Inc. · 2002-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Net Income: -537978 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -537978 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0001144204-04-003637.txt#3987 The citation records this snapshot. The page link may show a newer release later.	−USD 115,958 Exact value Exact value: -115958 USD 2002-01-01 – 2002-12-31: -115958 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VioQuest Pharmaceuticals, Inc. · 2002-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Operating Cash Flow: -115958 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -115958 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0000950134-03-001854.txt#3287 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 2.02 million Exact value Exact value: -2018400 USD 2003-01-01 – 2003-12-31: -2018400 USD Inspect Net Income Open source Share or cite Citation for Net Income · VioQuest Pharmaceuticals, Inc. · 2003-12-31 VioQuest Pharmaceuticals, Inc. (edgar:745788) Net Income: -2018400 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:12:40Z Snapshot: c52b7e98830935444de7cafa8e976654198530747d6fa9e0f2397c81fa817a0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/745788/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2018400 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/745788/0001144204-04-003637.txt#3987 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

60 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000745788, 745788, edgar:745788

Also known as CHIRAL QUEST INC, SURG II INC, SURGIDYNE INC, VioQuest Pharmaceuticals

VioQuest Pharmaceuticals, Inc.

Latest quarter

Revenue

Operating cash flow

Trailing twelve months

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2003 2003-01-01 – 2003-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation